Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 2 patents
14 readers on Mendeley
  • Article usage
  • Citations to this article (119)

Advertisement

Research Article Free access | 10.1172/JCI118351

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.

J Floege, W Kriz, M Schulze, M Susani, D Kerjaschki, A Mooney, W G Couser, and K M Koch

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Floege, J. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Kriz, W. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Schulze, M. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Susani, M. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Kerjaschki, D. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Mooney, A. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Couser, W. in: PubMed | Google Scholar

Division of Nephrology, Medizinische Hochschule, Hannover, Germany.

Find articles by Koch, K. in: PubMed | Google Scholar

Published December 1, 1995 - More info

Published in Volume 96, Issue 6 on December 1, 1995
J Clin Invest. 1995;96(6):2809–2819. https://doi.org/10.1172/JCI118351.
© 1995 The American Society for Clinical Investigation
Published December 1, 1995 - Version history
View PDF
Abstract

Podocyte injury is believed to contribute to glomerulosclerosis in membranous nephropathy. To identify the factors involved, we investigated the effects of basic fibroblast growth factor (bFGF), a cytokine produced by podocytes, on rats with membranous nephropathy (passive Heymann nephritis [PHN]). All rats received a daily i.v. bolus of 10 microg bFGF or vehicle from days 3-8 after PHN induction. In proteinuric PHN rats on day 8, bFGF injections further increased proteinuria. Podocytes of bFGF-injected PHN rats showed dramatic increases in mitoses, pseudocyst formation, foot process retraction, focal detachment from the glomerular basement membrane, and desmin expression. bFGF injections in PHN rats did not alter antibody or complement deposition or glomerular leukocyte influx. bFGF-injected PHN rats developed increased glomerulosclerosis when compared with control PHN rats. Also, bFGF induced proteinuria and podocyte damage in rats injected with 10% of the regular PHN-serum dose. None of these changes occurred in bFGF-injected normal rats, complement-depleted PHN rats or rats injected with 5% of the regular PHN serum dose. These divergent bFGF effects were explained in part by upregulated glomerular bFGF receptor expression, induced by PHN serum. Thus, bFGF can augment podocyte damage, resulting in increased glomerular protein permeability and accelerated glomerulosclerosis. This bFGF action is confined to previously injured podocytes. Release of bFGF from glomerular sources (including podocytes themselves) during injury may represent an important mechanism by which podocyte damage is enhanced or becomes self sustained.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2809
page 2809
icon of scanned page 2810
page 2810
icon of scanned page 2811
page 2811
icon of scanned page 2812
page 2812
icon of scanned page 2813
page 2813
icon of scanned page 2814
page 2814
icon of scanned page 2815
page 2815
icon of scanned page 2816
page 2816
icon of scanned page 2817
page 2817
icon of scanned page 2818
page 2818
icon of scanned page 2819
page 2819
Version history
  • Version 1 (December 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (119)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
14 readers on Mendeley
See more details